ABSTRACT SUBMISSION
Congress delegates are cordially invited to submit abstracts of their scientific work for presentation as a free communication at the IFCC Worldlab 2024 Congress.
An unlimited number of abstracts may be submitted provided the presenting author applies for “full registration” or “young registration”.
Abstracts are welcome in all fields of clinical chemistry, hematology, clinical molecular biology and laboratory medicine, in the broader sense. Free communications are primarily presented via poster. A limited number of abstracts will be selected for oral presentation during congress symposia. Authors wishing to compete for these oral communication slots should mark the appropriate field on the online abstract submission form.
GENERAL REQUIREMENTS
The text must be clear, concise, and written in proper English. The content must not have been previously published in academic journals or subject to peer review. Significant technical information must not be withheld. Abstracts must absolutely contain results. Statements such as “results will be discussed” are not acceptable and will lead to rejection.
GENERAL INFORMATION
- Deadline for receipt
Abstracts should be submitted by 22nd January 2024, 18:30 CET.
- Confirmation of receipt
Receipt of the abstract will be acknowledged by e-mail immediately after submission.
- Notification of acceptance or rejection
Authors will be notified of acceptance or rejection before 28th February 2024.
- Registration
The presenting author of each abstract must register for the congress with “Full Registration” or “Young Registration”.
HOW TO PREPARE AND SUBMIT AN ABSTRACT
It is important to carefully follow the instructions below. Incorrectly prepared abstracts will be rejected.
- Abstracts should be prepared off-line in advance;
- Prepare your abstract on a word processor (such as Microsoft Word);
- Do not include title, authors’ names and affiliations in the abstract file
- Tables and figures are not allowed;
- References are not allowed;
- When abbreviations are used, spell out the full word at first mention in the text followed by the abbreviation in parentheses. Thereafter, use the abbreviation throughout.
When the on-line system requires the abstract to be entered, copy and paste your text.
Abstracts are limited to 2300 characters, spaces included (title, authors’ names and affiliations excluded). The system will automatically notify you if the abstract exceeds this number of characters.
Title, author(s) and affiliation(s) must be added separately at the appropriate step.
IMPORTANT NOTICE
Abstract authors are asked to indicate the most suitable topic for presentation of their work and will also be asked whether they wish apply for an oral presentation during the scientific symposia. In that case, authors must also select the symposium in which they would like to give their presentation.
TOPICS
Aging & Longevity
| Accreditation, Patient Safety, Risk management, Quality Assurance, Audit |
| Artificial intelligence, clinical decision support and machine learning |
| Clinical Chemistry |
| Data Science , Digital health, big data and smart technologies |
| Demand/test utilization management |
| Direct to consumer testing |
| Disease specific biomarkers: autoimmune, bone, cardiac, cancer, diabetes, neurological, sepsis, traumatic brain injury, … |
| Emerging & Analytical technologies, applications and limitations |
| Emerging biomarkers (-omics type, …) |
| Endocrinology |
| Evidence based medicine, including Guidelines |
| Genetic diseases |
| Geriatric testing |
| Green laboratories |
| Healthcare reform: from curative to preventive |
| Hematology and hemostasis |
| Immunology |
| Integral Diagnostics, radiomics, … |
| Kidney diseases and transplantation, urinalysis, urinary biomarkers |
| Laboratory consolidation, Total lab automation and process design |
| Laboratory Information Systems and globalization of NPU |
| Laboratory Management, Medical leadership |
| Metabolic diseases |
| Metrological traceability and test standardization/harmonization |
| Microbiology – Infectious diseases including COVID 19 |
| Molecular diagnostics, including CTC and ctDNA |
| Neonatal and paediatric laboratory medicine, including prenatal testing |
| Nutrition Trace Elements and Vitamins |
| Point of Care testing, critical care, emergency medicine |
| Precision Diagnostics and Precision Medicine |
| Recruitment, Education and Training of workforces in Laboratory Medicine |
| Regulations and Regulatory Science, including suboptimal tests and post-market follow-up |
| Remote monitoring and preanalytical challenges |
| Test Evaluation, outcome studies, clinical utility of biomarkers |
| Total Test process, including preanalytics, analytics and postanalytics |
| Toxicology and TDM |
| Trends towards regional/national/global ICT connectivity and networks |
| Rare Diseases |
| Epigenetics |
| Aging & Longevity |
| Gut Microbiome |
| Biological Cellular Therapies |
| Others |